Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Seven-day contraceptive patch: Agile began a Phase II trial in the U.S. and Australia of its 7-day transdermal combination contraceptive patch in 162 subjects

Agile Therapeutics Inc., West Conshohocken, Penn.
Product:

Read the full 71 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE